Compare CSGS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSGS | AORT |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 1996 | 1993 |
| Metric | CSGS | AORT |
|---|---|---|
| Price | $79.85 | $43.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $72.96 | $49.36 |
| AVG Volume (30 Days) | ★ 481.9K | 269.4K |
| Earning Date | 02-03-2026 | 02-23-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | ★ 29.70 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $1,216,848,000.00 | $422,646,000.00 |
| Revenue This Year | $2.90 | $15.97 |
| Revenue Next Year | $4.71 | $10.96 |
| P/E Ratio | $27.05 | ★ N/A |
| Revenue Growth | 3.31 | ★ 9.81 |
| 52 Week Low | $52.94 | $21.97 |
| 52 Week High | $79.88 | $48.25 |
| Indicator | CSGS | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 76.87 | 44.14 |
| Support Level | $79.40 | $41.82 |
| Resistance Level | $79.69 | $45.99 |
| Average True Range (ATR) | 0.30 | 1.52 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 87.67 | 39.24 |
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.